GPRP acetate

GPRP acetate is a synthetic tetrapeptide composed of glycine, proline, arginine, and proline, commonly utilized in biochemical and molecular research. As a well-characterized peptide sequence, it is primarily recognized for its role as a specific inhibitor of fibrin polymerization, making it a valuable tool in the study of coagulation pathways and fibrin-related processes. Its defined structure and reliable activity have positioned GPRP acetate as a standard reagent in investigations of fibrin formation, clot stability, and protein-protein interactions within the hemostatic system.

Coagulation research: GPRP acetate is widely employed in studies focused on the mechanisms of blood coagulation. By competitively inhibiting the polymerization of fibrin monomers, it enables researchers to dissect the molecular steps involved in clot formation and stabilization. The peptide's ability to interfere with the binding of fibrin monomers at the "A" polymerization site allows for precise modulation of fibrin network assembly, facilitating detailed investigations into the regulation of coagulation and the identification of factors influencing clot architecture.

Fibrin structure-function analysis: In structural biology and protein chemistry, GPRP acetate serves as a molecular probe to elucidate the specific interactions between fibrinogen and fibrin during clot development. Its selective inhibition of fibrin assembly provides a controlled experimental environment to study the conformational changes and intermolecular contacts essential for fibrin fiber formation. This approach is instrumental in mapping critical binding sites, understanding the structural basis of fibrin-related disorders, and guiding the design of targeted anticoagulant strategies in preclinical models.

Platelet function studies: The peptide is also utilized in research exploring platelet-fibrin interactions. By blocking fibrin polymerization, GPRP acetate allows for the isolation and characterization of platelet activation events that are independent of fibrin network formation. This application is valuable for distinguishing the direct effects of platelet agonists from those mediated by the surrounding fibrin matrix, supporting the development of assays that clarify the contribution of platelets to thrombus formation under various experimental conditions.

Analytical assay development: GPRP acetate is incorporated into a range of analytical protocols designed to quantify fibrinogen activity, monitor fibrinolysis, or assess the efficacy of anticoagulant compounds in vitro. Its defined inhibitory action provides a reproducible means of controlling fibrin polymerization, enabling the calibration of turbidimetric, spectrophotometric, and other quantitative assays. The use of the peptide in these contexts enhances assay reliability, supports high-throughput screening, and contributes to the standardization of coagulation-related measurements across laboratories.

Peptide interaction studies: Beyond its applications in hemostasis, GPRP acetate is utilized as a model system for investigating peptide-protein and peptide-peptide interactions. Its predictable binding properties and sequence specificity make it a useful reference compound in biophysical studies, affinity measurements, and the validation of computational models that predict peptide binding motifs. These applications extend to the broader field of peptide research, where the compound's characteristics inform the rational design and optimization of novel bioactive sequences.

1. The spatiotemporal control of signalling and trafficking of the GLP-1R

2. Oleic acid and glucose regulate glucagon-like peptide 1 receptor expression in a rat pancreatic ductal cell line

3. P-selectin and Complement’s Role in a Neonatal Model of Germinal Matrix Hemorrhage-Induced Secondary Injury

4. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review

5. Emu oil in combination with other active ingredients for treating skin imperfections